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Abstract
Background: To understand the relationship between our bacterial microbiome and health, it is essential to define
the microbiome in the absence of disease. The digestive tract includes diverse habitats and hosts the human
body’s greatest bacterial density. We describe the bacterial community composition of ten digestive tract sites
from more than 200 normal adults enrolled in the Human Microbiome Project, and metagenomically determined
metabolic potentials of four representative sites.
Results: The microbiota of these diverse habitats formed four groups based on similar community compositions:
buccal mucosa, keratinized gingiva, hard palate; saliva, tongue, tonsils, throat; sub- and supra-gingival plaques; and
stool. Phyla initially identified from environmental samples were detected throughout this population, primarily
TM7, SR1, and Synergistetes. Genera with pathogenic members were well-represented among this disease-free
cohort. Tooth-associated communities were distinct, but not entirely dissimilar, from other oral surfaces. The
Porphyromonadaceae, Veillonellaceae and Lachnospiraceae families were common to all sites, but the distributions
of their genera varied significantly. Most metabolic processes were distributed widely throughout the digestive
tract microbiota, with variations in metagenomic abundance between body habitats. These included shifts in sugar
transporter types between the supragingival plaque, other oral surfaces, and stool; hydrogen and hydrogen sulfide
production were also differentially distributed.
Conclusions: The microbiomes of ten digestive tract sites separated into four types based on composition. A core
set of metabolic pathways was present across these diverse digestive tract habitats. These data provide a critical
baseline for future studies investigating local and systemic diseases affecting human health.
Background
The bacterial microbiome of the human digestive tract
contributes to both health and disease. In health, bac-
teria are key components in the development of mucosal
barrier function and in innate and adaptive immune
responses, and they also work to suppress establishment
of pathogens [1]. In disease, with breach of the mucosal
barrier, commensal bacteria can become a chronic
inflammatory stimulus to adjacent tissues [2,3] as well
as a source of immune perturbation in conditions such
as atherosclerosis, type 2 diabetes, non-alcoholic fatty
liver disease, obesity and inflammatory bowel disease
[4-8]. It is therefore critically important to define the
microbiome of healthy persons in order to detect signifi-
cant variations both in disease states and in pre-clinical
conditions to understand disease onset and progression.
The Human Microbiome Project (HMP) established
by the National Institutes of Health aims to characterize
the microbiome of a large cohort of normal adult sub-
jects [9], providing an unprecedented survey of the
microbiome. The HMP includes over 200 subjects and
has collected microbiome samples from 15 to 18 body
habitats per person [10]. This unique dataset permits
novel studies of the human digestive tract within a large
number of subjects, allows for comparisons of microbial
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tion of distinct metabolic niches within and among indi-
viduals. Previous studies of the healthy adult digestive
tract microbiota have typically included less than 20
individuals [11-21] and the studies with over 100 indivi-
duals have most often focused on a single body site
[22-26]. The increased throughput, the improved sensi-
tivity of assays and the improvements in next generation
sequencing technologies have enabled cataloging of
microbial community membership and structure
[12,19,27] as well as the metagenomic gene pool present
in each community in large numbers of samples from
large numbers of subjects. The HMP in particular
includes, for each sample, both 16S rRNA gene surveys
and shotgun metagenomic sequences, from a subset of
the subjects recruited at two geographically distant loca-
tions in the United States. The recruitment criteria
included a set of objective, composite measurements
performed by healthcare professionals [10], defining this
reference population and enabling this investigation to
focus on defining the integrated oral, oropharyngeal,
and gut microbiomes in the absence of host disease.
The focus of this study, complementary to other activ-
ities in the HMP consortium, was to measure and com-
pare the composition, relative abundance, phylogenetic
and metabolic potential of the bacterial populations
inhabiting multiple sites along the digestive tract in the
defined adult reference HMP subject population. The
digestive tract was represented by ten microbiome sam-
ples from distinct body habitats: seven samples were
from the mouth (buccal mucosa, keratinized attached
gingiva, hard palate, saliva, tongue and two surfaces
along the tooth); two oropharyngeal sites (back wall of
the oropharynx (refered to here as throat) and the pala-
tine tonsils); and the colon (stool). In addition to their
distinct anatomic locations, these sites were chosen
because sampling minimally disturbed the existing mico-
biota and involved minimal risk to participants.
Although existing data indicate that mucosa-associated
communities below the pharynx may have distinct
microbiomes, these sites were not included, as sampling
would have required invasive procedures [16,17,28].
The results show that the ten body habitats examined
here formed four categories of microbial community
types. These four community types included taxa typi-
cally classified as ‘environmental’ phyla. Genera charac-
terized by pathogenic species and thus associated with
disease were also widely distributed among the popula-
tion. Most striking, each body site (within as well as
between the four groups) possessed a highly distinctive
community structure with moderate variability across
the population, and with distinct abundances of some
microbial metabolic processes within each community.
The combination of high-throughput sequencing
technologies and a large, well-characterized study popu-
lation has thus provided quantitative and qualitative out-
puts that allow a comprehensive definition of the
normal adult digestive tract microbiome.
Results
Microbial community structure indicates four distinct
community types within the ten digestive tract sites
At all phylogenetic levels, from phylum to genus, we
identified four groups of body habitats that maintain a
distinct pattern of numerically dominant bacterial taxa
as profiled using the 16S rRNA gene (Figure 1a), as clas-
sified by the Ribosome Database Project (RDP) [29].
While only two phyla, the Firmicutes and Bacteroidetes,
dominated the communities of all ten sites, their pro-
portions and that of nearly all taxa in the sampled body
habitats form groups as follows: Group 1, buccal
mucosa, keratinized gingiva, and hard palate; Group 2,
saliva, tongue, tonsils, and throat (back wall of orophar-
ynx); Group 3, sub- and supra-gingival plaque; and
Group 4, stool. The microbiota of Group 1 consisted
mostly of Firmicutes followed in decreasing order of
relative abundance by Proteobacteria, Bacteroidetes and
either Actinobacteria or Fusobacteria (Figure 1a; Addi-
tional file 1). In comparison, Group 2 had a decreased
relative abundance of Firmicutes and increased levels of
four phyla: Bacteroidetes, Fusobacteria, Actinobacteria
and TM7. Group 3, which consisted of both tooth pla-
que sites, had a further decrease in Firmicutes compared
to Groups 1 and 2, with a marked increase in the rela-
tive abundance of Actinobacteria. Finally, the stool
microbiota (Group 4) consisted of mostly Bacteroidetes
(over 60%) followed by Firmicutes, with very low relative
abundances of Proteobacteria and Actinobacteria, and
less than 0.01% of Fusobacteria (Additional file 1).
These dramatic differences occurred consistently
throughout the cohort, with closely juxtaposed body
sites (for example, tongue dorsum (Group 2) and hard
palate (Group 1)) possessing strikingly different micro-
bial community structure even when considering the
phylum level alone and independently of the structure
of the tissue (Additional file 2). This supports strong
local selective pressure on community membership even
in the absence of disease, and these differences reach to
the genus level (Figure 1a). In terms of genera, Group 1
was characterized by a very high relative abundance of
Streptococcus, while Group 4 contained predominantly
Bacteroides. In contrast, Groups 2 and 3, rather than
having a single genus present at such high relative abun-
dance, were characterized by a more even distribution of
the most abundant genera. Streptococcus, Veillonella,
Prevotella, Neisseria, Fusobacterium, Actinomyces and
Leptotrichia were each present over 2% on average in
Group 2. These seven genera plus Corynebacterium,
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for genera present at more than 2% in Group 3 (Figure
1a; Additional file 1).
Examining clade abundances at all taxonomic levels,
we used the LEfSe (LDA Effect Size) system for biomar-
ker discovery [30] to determine statistically significant
biomarkers among these four groups within the diges-
tive tract. These included both high and low abundance
clades that significantly and consistently varied in abun-
dance among and within body habitats, for example, in
the three oral groups (Figure 1b; Additional file 3). For
example, both the phylum Actinobacteria and individual
taxa within the Actinomycetales were consistently more
abundant on the tooth surfaces in Group 3 (Figure 1b;
Additional file 3). When comparing Group 1 against the
other three groups (a slightly more stringent setting
than comparing all groups against each other as in Fig-
ure 1b and Additional file 1) two genera from the Firmi-
cutes were identified as genus-level biomarkers:
Streptococcus, from the Streptococcaceae (mean 47 ±
18% abundance in Group 1), and Gemella, from the Sta-
phylococcaceae (mean 5.2 ± 5.1% abundance in Group
1) (Additional file 1). Although the Firmicutes phylum
as a whole was most differentially abundant in Group 1,
more specific taxa within the Firmicutes were detected
as biomarkers for Groups 2 and 4 (Figure 1b; Additional
file 3). For example, in Group 2, biomarkers, when com-
pared to the other three groups, included Oribacterium
and Catonella, members of the Lachnospiraceae, and
Veillonella, a member of the Veillonellaceae (all Clostri-
dia). The abundances of Veillonella and Prevotella over-
all were comparable in Group 2 (10.2 ± 5.4% versus
11.6 ± 7.3%, respectively), and both were identified as
differentially abundant in this group. The other genus-
level biomarkers for Group 2 detected at >2% were Por-
phyromonas (3.8 ± 4.2%) and Neisseria (6.6 ± 7.6%)
(Additional file 1). Several genus-level biomarkers for
Group 4 (stool) were also Firmicutes, mostly from the
families Lachnospiraceae and Ruminococcaceae (Figure
1b; Additional file 3). These results support the overall
consistency of the different microbial populations char-
acterizing each of the four groups, and they also empha-
size the need to take multiple levels of phylogenetic
specificity into account when performing any analysis of
Figure 1 Groups detected in the sampled digestive tract microbiome sites based on similarities in microbial composition. (a)
Taxonomic composition of the microbiota in the ten digestive tract body habitats investigated based on average relative abundance of 16S
rRNA pyrosequencing reads assigned to phylum (upper chart) and genus (lower chart). Microbiota from the ten habitats are grouped based on
the ratio of Firmicutes to Bacteroidetes as follows: Group 1 (G1), buccal mucosa (BM), keratinized gingiva (KG) and hard palate (HP); Group 2 (G2),
throat (Th), palatine tonsils (PT), tongue dorsum (TD) and saliva (Sal); Group 3 (G3), supraginval (SupP) and subgingival plaques (SubP); and Group
4 (G4), stool (Stool). Labels indicate genera at average relative abundance ≥2% in at least one body site. The remaining genera were binned
together in each phylum as ‘other’ along with the fraction of reads that could not be assigned at the genus level as ‘unclassified’ (uncl.). See
Additional file 1 for detailed values. (b) Circular cladogram reporting taxa consistently differential among the body habitats in at least one group
detected using LEfSe. Colors indicate the group in which each differential clade was most abundant. See Additional file 3 for the detailed list of
taxa whose representation was statistically different among the groups. The representation is based on RDP phylogenetic hierarchy.
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tiated very distinct body habitats. As additionaly dis-
cussed below, these differences were reflected at the
genus level within each body site in the healthy adult
human.
The four observed groups differed significantly not
only based on their specific microbial compositions, but
also by several ecological summary statistics. Most strik-
ingly, after comparing every pair of samples using the
Bray-Curtis measure of beta diversity [31], within-group
distance was very significantly lower (greater similarity)
than between-group distance (lower similarity) for all
four groups (Additional file 4; Table 1; all P <1 0
-20).
The coarse level of species richness measurement
offered by phylotype data did not distinguish strongly
among any body habitats, but evenness and the resulting
within-community alpha diversity ranged widely among
groups as measured by the inverse Simpson index [32]
(Additional file 5). For example, the Group 1 body sites
together averaged below a relative diversity of 5.3,
Group 2 ranged from 7.3 ± 3.0 (tonsils) to 10.6 ± 3.1
(saliva), the plaques in Group 3 had average diversities
o f9 . 6±3 . 1a n d9 . 8±3 . 0 ,a n dG r o u p4( s t o o l )d e c l i n e d
to a mean of 4.6 ± 2.9. The lower diversities in Group 1
are largely an effect of Streptococcus abundance, and
likewise the gut microbiota’s diversity is lowered by the
prevalence of the Bacteroides i nt h e s ed a t a( b o t h
detailed above and below). These differences are highly
statistically significant (for example, Group 1 versus 2 P
<1 e - 5 0b yt-test) and provide evidence in support of
the four-group distinction at the levels of both indivi-
dual bacterial clade and overall ecological structure.
Phyla typically identified with environmental
communities are part of the natural microbiota of healthy
humans
Bacterial phyla originally thought to be exclusively envir-
onmental have recently been observed to possess human
host-associated membership [33-36]. This phenomenon
was widely observed within this normal population. The
phylum TM7 was highly prevalent, detected in at least
one sampling site of the upper digestive tract of 85% of
subjects and in the stool of 13.6% of the subjects (Addi-
tional file 6). The phyla SR1 and Synergistetes were pre-
sent in at least one upper digestive tract site of 65.3%
and 58.5% of the subjects and in the stool of 1.4% and
8.8% of the subjects, respectively. The phylum Verruco-
microbia, represented mainly by the genus Akkermansia
[35], and the phylum Lentisphaerae, represented by the
genus Victivallis [ 3 4 ] ,w e r ep r e s e n ti nt h el o w e rd i g e s -
tive tract of 41.5% and 15.0% of the subjects and in the
upper digestive tract of 13.6% and 1.4% of the subjects.
TM7 bacteria accounted for a mean of 3.1 ± 5.7% of the
saliva population and 0.6 ± 1.2% of the bacteria found
in plaque communities (Figures 1a and 2; Additional file
1). The SR1 phylum was also most abundant in saliva
(mean 0.4 ± 1.2%), and both TM7 and SR1 phyla were
found at trace amounts in stool. While these phyla were
varyingly prevalent (Figure 2), they occurred near-uni-
formly at low but significantly non-zero abundances,
which highlights their lack of detection in smaller stu-
dies without deep high-throughput sequencing.
Genera characterized by pathogenic members and thus
associated with disease were prevalent at low abundance
in the normal human microbiota
Clades populated with known bacterial oral pathogens
were well represented in this reference adult cohort,
typically with moderate to high population penetrance
but low relative abundance in each individual. Among
the Spirochetes, Treponema species are associated with
periodontal and endodontic diseases [37,38] and were
present in at least one of the upper digestive tract sites
of 96% of this disease-free population (and in all the
nine oral sites of 6.8%). Treponema had a variable rela-
tive abundance among the oral body habitats, with high-
est representation in the subgingival biofilm (mean 2.2 ±
4.1%) and non-zero abundances in several other sites,
for example, palatine tonsils (Figure 3; Additional file 1).
In contrast, a minority of stool samples (3.4%) contained
Table 1 Community structure similarity is higher for samples in the same digestive tract group than for samples in
different groups or outside the digestive tract
Digestive tract groups Non-digestive
G1 G2 G3 G4 tract samples
G1 0.58 ± 0.14 0.43 ± 0.17 0.32 ± 0.13 0.02 ± 0.03 0.04 ± 0.06
G2 0.43 ± 0.17 0.51 ± 0.14 0.39 ± 0.11 0.05 ± 0.05 0.04 ± 0.06
G3 0.32 ± 0.13 0.39 ± 0.11 0.49 ± 0.14 0.03 ± 0.04 0.07 ± 0.08
G4 0.02 ± 0.03 0.05 ± 0.05 0.03 ± 0.04 0.53 ± 0.17 0.03 ± 0.07
Non-digestive tract 0.04 ± 0.06 0.04 ± 0.06 0.07 ± 0.08 0.03 ± 0.07 0.29 ± 0.31
Average Bray-Curtis index and standard deviations are reported for samples in each of the four digestive tract groups and body sites outside of the digestive
tract. In bold are highlighted the within group similarity values that are statistically significantly higher (t-test P < 1e-20) than any between-group distances. The
body sites outside of the digestive tract included three vaginal sites (posterior fornix, mid-vagina, vaginal introitus), the nasal cavity (anterior nares), and two skin
sites (antecubital fossae and retroauricular crease).
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abundances of the phyla TM7, Synergistetes (Synerg.), and SR1 among the subject population, expressed as percentage on a log scale (left). The
high relative abundances of members of these phyla among the subjects, in particular for TM7, indicate a potential role in eubiosis. The body
habitats and groups are labeled as in Figure 1.
Figure 3 Most microbes in the digestive tract communities vary widely in relative abundance among body habitats and individuals.
Genera with the lowest (top) to highest (bottom) variability among samples spanning all ten body sites, with coefficients of variation reported
numerically (right column) and relative abundance colored on a log scale. The scale bar shows the color-coding of the average relative
abundance expressed as percentage, from low (black) to high (red). All genera present >0.001% in at least half of the samples are reported.
Prevotella, Veillonella, and Streptococcus are least variable across both body sites and individuals.
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Page 5 of 18trace levels of Treponema. The previously published rar-
ity and specificity of Brachyspira to the gut was con-
f i r m e db yi t sd e t e c t a b l ep r e s e n c ei no n l yo n es t o o l
sample (226 stool samples in total; Additional file 7) and
absence from all the upper digestive tract sites (1,879
samples; Additional file 7). Other periodontal pathogens
were lower in abundance. Aggregatibacter were found
mostly along the tooth surfaces (Group 3; mean 0.4 ±
0.7/0.8% from supra- and sub-gingival biofilms), and
Megasphaera were found mostly in Group 2 (from
mean 0.4 ± 0.6% in the tonsils and tongue dorsum to
0.8 ± 0.9% in saliva). Bifidobacteriaceae, implicated in
the formation of caries [39,40], were very rare at all oral
sites (means <0.03%), but possessed high prevalence
(40.8%). In the stool, the genus Bifidobacterium was
most represented with a low mean relative abundance of
0.08 ± 0.3%. The low abundance of Bifidobacteriaceae in
the oral cavity may be a reflection of the lack of carious
lesions in this healthy subject population. Porphyromo-
nas, which includes Porphyromonas gingivalis (one of
the most studied oral pathogens) and non-pathogeneic
strains, was present in the upper digestive tract of all
the subjects (mean 3.0 ± 3.8%, 3.8 ± 4.2%, and 3.0 ±
3.5% in the three oral groups, respectively) and in 25%
of the lower digestive tract samples, though in very low
abundance in the stool (Additional file 1). Tannerella,
thought to incur similar host phenotypes, was present in
the upper digestive tract of 97.3% and in the stool of
3.4% of the subjects. Both genera, Porphyromonas and
Tannerella, were almost uniquely distributed in average
abundance among individual body sites within the oral
cavity, whereas the other relevant genera in the family
Porphyromonadaceae (Parabacteroides, Barnesiella,
Odoribacter, and Butyricimonas) predominantly colonize
the stool (Figure 4).
Genera that include important human pathogens colo-
nizing the throat/tonsils - Streptococcus pneumoniae,
Streptococcus pyogenes, Neisseria meningitidis,a n dHae-
mophilus influenzae - were all well represented in the
microbiota of the upper digestive tract sites (Figure 1a;
Additional file 6). The known difficulty of performing spe-
cies-level identification from 16S rRNA pyrosequencing
experiments [41] precluded the determination of preva-
l e n c ef o rt h e s es p e c i f i cp a t h o g e n si nt h i sc o h o r t .T h e
genus Moraxella, which includes the common sinus
pathogen Moraxella catarrhalis, was detected in the upper
digestive tract microbiota at low relative abundance,
reaching a mean >0.5% only in the throat (Additional file
1). Interestingly, the high standard deviation (4.7%) of the
relative abundances of Moraxella in the throat suggested
variable colonization within this population.
In the lower intestinal tract, genera containing known
pathogens were typically low in both prevalence and
relative abundance. Helicobacter, implicated in
gastrointestinal diseases, appeared in only 1.4% of stool
samples in trace amounts while studies of Helicobacter
pylori stool antigen prevalence in healthy European
adults ranged up to 33% [42]. Enterobacteriaceae abun-
dances were uneven among individuals in the gut and
within each individual among body sites, with the most
abundant genus being the Escherichia/Shigella complex
(mean 0.1 ± 0.67%), which was detected in 33% of stool
samples. Finally, Faecalibacterium,ag e n u so fc o n s i d e r -
able interest due to its observed decrease in abundance
in active Crohn’s disease [43-46], was highly represented
in the stool (98% of subjects and mean 4.6 ± 5.2%) but
present only at trace levels in the oral cavity (always
below 0.05%), suggesting that it may be adapted to a
very specific niche within the gut.
Comparison of microbial communities from the two tooth
surface-associated sites
Within the oral cavity, the Group 3 sub- and supra-gingi-
val plaque bacterial communities were most distinct and
differed strongly from the other body sites, but further dif-
ferences characterized each of these two sites individually.
The tooth surface adjacent to the soft gingival tissues spe-
cifically comprises two distinct ecological niches, supragin-
gival, and subgingival (Additional file 8). The supragingival
region sits above the gingival margin, exposed to the oral
cavity, bathed in saliva and exposed to ingested substances;
the subgingival region is bathed in a serum transudate that
flows from the base of the crevice outward to the oral cav-
ity. A key known physiological difference between these
two regions is the lower redox potential found subgingiv-
ally [47]. Correspondingly, we observed differences in the
non-diseased plaque biofilm communities from these two
regions distinguished by proportional shifts consistent
with these physiological distinctions (Figure 5a; Additional
file 1). Shifts at the phylum level were driven by subgingi-
val increases in the obligate anaerobic genera Fusobacter-
ium, Prevotella, and Treponema, and by lesser relative
abundances of Dialister, Eubacterium, Selenomonas, and
Parvimonas. In contrast, groups significantly increased in
the supragingival plaque consisted predominantly of facul-
tative anaerobic genera, including Streptococcus, Capno-
cytophaga, Neisseria, Haemophilus, Leptotrichia,
Actinomyces, Rothia, Corynebacterium, and Kingella (Fig-
ure 1a; Additional file 1). This suggests that along these
tooth surfaces, where direct bacterial interaction with host
cells is diminished, oxygen availability - an environmental
factor - may be a major driver of community composition.
The oropharyngeal microbiota lacked abundant site-
specific bacteria across all samples when compared to
the mouth
The pharynx is the site of carriage of a number of impor-
tant bacterial pathogens that impact both healthy and
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samples did not identify any genus-level organisms charac-
teristic of the microbiome of the throat and/or tonsils con-
sistently present above our limit of detection. For example,
when throat and tonsil samples were compared to the
mouth sites, the genera Butyrivibrio and Mogibacterium
(both from the phylum Firmicutes) were identified as dif-
ferentially abundant, but both were present at only low
levels (mean 0.057 ± 0.09%, and 0.188 ± 0.316%, respec-
tively, corresponding to only approximately 1 to 5
sequences/sample; Additional file 1). The palatine tonsils,
located in the oropharynx, are unique among the sites
Figure 4 Genera within the Porphyromonadaceae, Veillonellaceae and Lachnospiraceae families are differentially abundant across
microbial communities between the upper and lower digestive tract. These three families were detected among all ten digestive body
habitats, but genera within them showed varying patterns of niche specialization to sites along the digestive tract. All genera with at least
0.001% abundance in at least one body site are reported here. Clades showing a statistically significant difference (by LEfSe) specifically between
oral and stool samples are indiocated with asterisks. Abundances are reported on a log scale as averages. The scale bar shows the color-coding
of the average relative abundance expressed as percentage, from low (black) to high (red). The Porphyromonadaceae family is interesting in that
its average abundances are higher in the gut than in the oral body habitats, but specific genera within the family diverge: Tannerella and
Porphyromonas are predominantly present in the oral cavity, whereas Parabacteroides, Barnesiella, Odoribacter and Butyricimonas show higher
relative abundances in the gut. BM, buccal mucosa; KG, keratinized gingiva; HP, hard palate; Th, throat; PT, palatine tonsils; TD, tongue dorsum;
Sal, saliva; SupP, supraginval; SubP, subgingival plaques.
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ever, the genus-level tonsil-specific biomarker when com-
pared to the mouth, Peptococcus, was again present at very
low relative abundance (mean 0.049 ± 0.079%; Additional
file 1). This lack of throat- or tonsil-specific biomarkers
among bacterial taxa with a relative abundance >1% likely
reflects the similarity of the microbiome of these two oro-
pharyngeal sites with those of the tongue dorsum and sal-
iva (Group 2 in Figure 1) despite their differences in tissue
type (Additional file 2). This observation is supported by
the comparison of the complete Group 2 with all other
groups, which revealed distinct and abundant biomarkers
as discussed above (Figure 1b; Additional file 3). Micro-
biota composition and the path of swallowed saliva suggest
a potential role of saliva as one of the host factors influen-
cing microbiota of Group 2.
No genus-level microbial biomarkers characterize the
entire digestive tract microbiota as contrasted with non-
mucosal body habitats
After analyzing the microbiota of body habitats within
the digestive tract, we next asked if there were bacteria
whose differential abundance characterized the digestive
tract as a whole. The non-mucosal sites sampled in the
HMP included anterior nares, both post-auricular
creases (crease behind the ear), and both antecubital fos-
sae (inner elbow crease). Propionibacterium, Staphylo-
coccus, and Pseudomonas were identified as
biomarkers for the non-mucosal sites, based on a LEfSe
analysis of all ten digestive tract sites versus the non-
mucosal sites (Figure 5b). However, no genus-level bio-
markers were identified as uniquely present throughout
the digestive tract microbiota. The unclassified Veillo-
nellaceae and Porphyromonadaceae (Figure 5b) are unli-
kely to be true biomarkers due to their low
representation. Further analysis was impaired by the
lack of reference sequences for them within RDP. Mem-
bers of Veillonellaceae and Porphyromonadaceae
families were much less abundant at non-mucosal sites,
and were essentially absent from the HMP vaginal sam-
ples, suggesting that their adaptation is to the digestive
tract mucosa rather than mucosal surfaces in general.
Bacterial families common throughout the digestive tract
possess variable distributions of genera distinct to upper
and lower sites
Bacterial genera membership overlap in the same sub-
ject between oral and stool samples was limited when
Figure 5 Niche specialization is widespread throughout the digestive tract even among adjacent body habitats. (a) Circular cladogram
based on the RDP Taxonomy [29] reporting taxa significantly more abundant in supragingival (red) and subgingival plaque (green) and
demonstrating the extensive specialization even at these highly related sites. At the class level, Actinobacteria, Bacilli, Gamma-proteobacteria,
Beta-proteobacteria, and Flavobacteria are characteristic of the supragingival plaque, whereas Fusobacteria, Clostridia, Epsilon-proteobacteria,
Spirochaetes, Bacteroidia, and unclassified Bacteroidetes are biomarkers for the subgingival plaque. (b) Circular cladogram comparing the
digestive tract (red, GI) with non-mucosal body habitats (green, NON-GI: comprising samples from the anterior nares, and from the bilateral skin
sites, antecubital fossae, and retroauricular creases). Only a few clades are detected as differentially present and abundant throughout the entire
digestive tract, as the high degree of specialization and community variability at each body site prevents any individual community member
from being representative of all ten body habitats. BM, buccal mucosa; TD, tongue dorsum; SupP, supraginval.
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included Bacteroides, Faecalibacterium, Parabacteroides,
Eubacterium, Alistipes, Dialister, Streptococcus, Prevo-
tella, Roseburia, Coprococcus, Veillonella, Oscilibacter,
and yet-to-be-classified genera from a subset of families
(Additional file 6). Interestingly, the presence of genera
in a large portion of subjects was not related to a stable
relative abundance in the microbial communities, as
Bacteroides and Dialaster were among the four most
variable genera among subjects. In contrast, Prevotella,
Veillonella and Streptococcus were the genera with the
most consistent presence in the subject population (Fig-
ure 3). The importance of Lachnospiraceae, Veillonella-
ceae, and Porphyromonadaceae families in the healthy
digestive tract microbiome was indicated by their rela-
tive abundance among all body habitats and among sub-
jects (Figures 1 and 4; Additional files 1 and 6). Bacteria
of the Lachnospiraceae and Veillonellaceae families spe-
cifically were present in all subjects’ oral cavities and
stools (Additional file 6). Porphyromonadaceae were
present in the oral cavity of all subjects and the stool of
95.9% of subjects (Additional file 6), although their rela-
tive abundance of member genera varied by body habi-
tat (Figure 4). Porphyromonas was present primarily in
the oral sites, while Parabacteroides, Barnesiella, Odori-
bacter and Butyricinomonas were predominant in the
stool (Figure 4). The significance of this variation in
genus distribution was confirmed by LEfSe conmpari-
sons of the upper (oral) and lower (stool) digestive tract
sites (Additional file 3). In contrast, Tannerella (Figure
4) was present in most oral sites, but due to a lower
relative abundance specifically in the keratinized gingiva,
it was not found to be statistically signicant between the
oral and gut sites. The pattern of variable genus distri-
bution between the upper and lower parts of the diges-
tive tract holds for the Lachnospiraceae and
Veillonellaceae as well (Figure 4), again suggesting a pat-
tern of niche specialization among human body habitats
extending from the bacterial family level down to speci-
fic genera.
Differential representation of microbial metabolic
function among body sites using reconstruction from
whole shotgun sequencing
In addition to relative abundances of bacterial organisms
based on 16S rRNA genes, we examined the abundances
of microbial metabolic pathways as profiled from meta-
genomic shotgun sequencing of a subset of the available
b o d yh a b i t a t s[ 4 8 ] .T h e s ed a t af r o mt h eH M Pi n c l u d e d
one body site within each of the four digestive tract
groups: the buccal mucosa (Group 1), the tongue dor-
sum (Group 2), the supragingival plaque (Group 3) and
the stool (Group 4). The data analyzed below include
the relative abundances of individual enzyme families
(Kyoto Encyclopedia of Genes and Genomes (KEGG)
Orthologous groups (KOs) [49]) and of complete meta-
bolic modules (KMods) (Figure 6; Additional file 9).
Bacterial cells use a wide variety of aerobic or anaerobic
degradation pathways as energy sources, and this was
most evident in the differences in relative abundance of
specific sugar transporters when comparing the oral sites
to the gut. PTS transporters for small sugars were most
abundant in the oral cavity and were represented for
monosaccharides by mannose (M00276) and fructose
(M00304) transporters, as well as the transporter of
galactosamine (M00287), derived from the breakdown of
sugar-decorated glycoproteins. The supragingival plaque
microbiome was enriched for threhalose (M00270,
M00204), alpha-glucosides (M00201, M00200), and cello-
biose (M00206) transport; in contrast, the stool micro-
biome was enriched for the transport of lactose/
arabinose (M00199) and oligogalacturonide (M00202),
and for the degradation of the larger dermatan (M00076),
chondroitin (M00077) and heparin (M00078) sulfate
polysaccharides. Surprisingly, while anaerobiosis-related
pathways were expected throughout the digestive tract,
putrescine transporters in particular were most repre-
sented in the oral cavity (M00193, M00300). This is of
potential interest as concurrent production and import of
putrescine is a delicate balance, and excess putrescine is
one source of halitosis [50].
Consistent with what is known about the function of
the colonic gut bacteria, we observed several prominent
enzymes and metabolic pathways most abundantly in
the stool metagenome. For instance, b-glucosidase
(K05349) was specifically abundant in the gut micro-
biota and not at oral sites; this enzyme is critical in the
pathway of cellulose breakdown to b-D-glucose. Conco-
mitantly, given that the Embden-Meyerhoff pathway is
also known to be the major route for glucose metabo-
lism to pyruvate in the colon, the highly associated gly-
colysis pathway module (M00001) was also significantly
enriched in stool [51]. This finding is further in agree-
ment with the 16S rRNA gene sequencing data, which
included prevalent Ruminococcus in stool that are
important colonizers of plant-derived material in the gut
and possess cellulolytic activity [52]. The stool bacteria
were also uniquely associated with pathways for ammo-
nia (M00028, urea cycle, and M00029, ornithine bio-
synthesis) and methane (M00356 and M00357, both
methanogenesis) production; the prominence of these
enzymes is consonant with the colonic microbiome as a
significant source of ammonia production. In fact, tar-
geting the colonic microbiome with antibiotics has been
shown to be a successful therapy in acquired diseases of
hyperammonemia such as encephalopathy complicating
hepatic insufficiency [53]. Relatedly, compared to upper
digestive tract sites, there was very high abundance of a
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and association with the pyruvate:ferredoxin oxidoreduc-
tase pathway, which, due to its role in converson of
metronidazole to its active nitroso form, can also deter-
mine sensitivity to this antibiotic. These potential patho-
genically linked behaviors are of course in addition to
the expected colonic bacterial activities detected for pro-
ducing energy from undigested cellulose, nitrogen-con-
taining compounds, and vitamins and cofactors
important in support of basic metabolic pathways.
Although HMP protocols were optimized for bacterial
sequences, shotgun sequencing also provides an initial
means of assessing the community structure of non-16S
assayable microbes. As reported in Additional file 10,
the fractions of Archaea (0.04% in the stool; below the
detection threshold in the oral cavity) and small eukar-
yotes (0.34% in the buccal mucosal; <0.1% in the other
body sites) detected here proved to be very small.
Although this may be due in part to the HMP’s specific
DNA handling protocols [10], this suggests that 16S
rRNA gene-based community surveys provide an
accurate overview of these digestive-tract associated
microbial communities. Likewise, ribosomal and shotgun
sequencing in the HMP cohort have been compared
elsewhere and provide consistent quantitative estimates
of genus-level abundances [54] without systematic phy-
lum-level biases.
Integration of gene/pathway abundances from
metagenomic data and bacterial clades based on 16S
rRNA gene data
A subset of the HMP’s microbiome samples was assayed
with both shotgun metagenomic and 16S rRNA gene
sequencing. This allowed us to assess co-variation of
microbial abundances with inferred metabolic pathways.
Strong correlations between the abundances of bacterial
clades (from 16S rRNA data) and gene or pathway
abundances (from metagenomic data) in some cases
clearly highlighted genes carried by these organisms,
and in others denoted less clear pangenomic elements
or metabolic dependencies. An example of the former
was the arabinofuranosyltransferase genes aftA and aftB
Figure 6 Functional characterization of the digestive microbiota based on metabolic pathway abundances in the buccal mucosa,
supragingival plaque, tongue dorsum, and stool from metagenomic shotgun sequencing. Cladogram represents the KEGG BRITE
functional hierarchy, with the outermost circles representing individual metabolic modules and the innermost very broad functional categories.
Pathways coloration denotes modules showing significant differential abundances in at least one of the four body habitats. Metabolic profiling
was performed with HUMAnN [48], revealing a much lower degree of variability among individuals and significant specifity of many pathways’
relative abundance to individual body habitats. In particular, sugar transport and metabolism varies at each of the four habitats with
metagenomic data, as does iron uptake and utilization.
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the tooth surface habitats and are known to be encoded
by Corynebacterium, a biomarker of the plaques as dis-
cussed above. This was confirmed by the genes’ strong
association with Corynebacterium clades in these data
(Spearman correlation 0.76, P-value <1e-15; Additional
file 11). Archaea were not included in our analysis, as
these were not detectable by 16S rRNA gene sequencing
(due to lack of the conserved sequence in the primers
used) and were poorly represented in the shotgun
sequencing data.
The acquisition and export of metals for bacterial
homeostasis and for pathogenicity is ubiquitous
throughout the human microbiota, with iron being most
generally necessary. Iron transporters were widely dis-
tributed among the microbiota of all four body sites, but
again, the specific mechanisms of iron uptake and
sequestration differed as needed for niche specialization.
One use of the iron is its incorporation in porphyrin,
and there was a wide distribution of cytochrome c heme
lyase (K01764), which appeared to be ubiquitous and
was not strongly associated with individual organisms.
Conversely, uroporphyrinogen synthase (K01719)
occurred at higher relative abundance in stool, inversely
associated with members of the Clostridiales (Spearman
correlation -0.79, P-value <1e-15; Additional file 11).
This can be contrasted to protoporphyrinogen oxidase
(K00231) in the oral cavity, which is potentially linked
to the Prevotella enrichment (Spearman correlation
0.71, P-value <1e-15). Within the oral cavity specifically,
coproporphyrinogen oxidase (K00228) and protopor-
phyrinogen oxidase (K00231) were both more abundant
on the tongue and in supragingival plaque than on the
buccal mucosa, expected to be linked to the increased
relative abundance of Porphyromonas and Prevotella on
those surfaces [55] (Figure 1; Additional file 11).
Metal export and utilization were likewise ubiquitous
throughout the microbiota, but differed in the preva-
lence of specific mechanisms. Most genes encoding
exporters needed for heme tolerance [56], such as
MtrCDE (K00579, K00580) and HrtAB (K09814,
K09813), were present at low levels throughout the
digestive tract, although MtrCDE was somewhat
enriched in the more anaerobic habitats, stool and pla-
ques. None were significantly associated with specific
organisms in these data. The gene encoding hemerithryn
(K07216) was detected at multiple body sites but was
highly enriched in stool. This enzyme for iron utilization
is most often found in members of the Methylococca-
ceae family [57], but these were again not detectable in
this study due to their absence from the RDP 16S rRNA
database (see Materials and methods). Intriguingly, the
hemerithryn (K07216) gene consistently associated with
members of the Clostridiales when present in the gut
(Spearman correlation 0.72, P-value <1e-15; Additional
file 11). Finally, other metals, including copper and zinc,
are also both necessary co-factors and potential toxins,
and remediation pathways and transporters for both
were observed consistently (copper resistance K07245;
copper homeostasis K06201, K06079; zinc resistance
K07803; and also many other metal transporters).
Although recent work has provided extensive insights
into the mechanisms of bacterial interaction with the
host immune system in the gut, much less is known
about the relationship of the microbiota with host
immunity for other body habitats and cell types. Two
pathways observed in both the upper and lower diges-
tive tracts and known to be involved in immunomodula-
tion were hydrogen (H2) and hydrogen sulfide (H2S)
production. Hydrogen production has been shown to be
an important byproduct of acetogenic bacteria and also
has an anti-inflammatory activity [58]. Enzymes both for
utilization (for example, CoM methyltransferase,
K14082) and for production (for example, hydrogenase-
4, K12136) of hydrogen were identified specifically in
the oral cavity (nearly completely absent from the gut),
with potential bacterial contributors including Veillo-
nella and Selenomonas species genomically [59] and, in
one of the strongest links between genes and organisms
in these data, an unclassified Pasteurellaceae clade in
the oral cavity (Spearman correlation for K12136 >0.78,
P-value <1e-15 in supragingival placque and tongue
dorsum).
Hydrogen sulfide gas is involved in regulation of the
host response at low concentrations and in host-cell
toxicity and inhibition of short chain fatty acid produc-
tion, specifically in the colon, at high concentrations
[60-65]. H2S may thus serve different purposes among
the distinct bacterial communities of the digestive tract.
The potential for its production was particularly
enriched in stool (for example, by cystathione-beta-
lyase, K14155), and somewhat enriched in the more
anaerobic habitats, stool and plaques (for example, by
methionine-gamma-lyase, K01761). A possible role in
host-cell toxicity was strongly suggested by K01761’s
close association with the Treponema and Fusobacter-
ium genera in plaque (Spearman correlation 0.74 and
0.82, respectively, P-values <1e-15), both of which
include members specifically associated with periodontal
disease (Additional file 11). These genes were again,
however, present at low levels among all body sites ana-
lyzed here, consistent with a low-level immunomodula-
tory role for H2S throughout the digestive tract.
Discussion
The large reference population of the HMP has pro-
vided, to our knowledge, the first opportunity for a
comprehensive description of the human gastrointestinal
Segata et al. Genome Biology 2012, 13:R42
http://genomebiology.com/2012/13/6/R42
Page 11 of 18microbiota, focused here on the bacterial composition
and function of ten independently sampled body habi-
tats throughout the digestive tract. Using taxonomically
binned 16S rRNA gene sequences, we identified the
representation and relative abundance of organisms in
2,105 samples. We used the LEfSe system for metage-
nomic biomarker discovery to identify clades at all taxo-
nomic levels whose distribution varied among four
classes of body habitats, and which included rare clades
not expected as commensals in the human microbiome.
We also observed prevalent but low abundance of gen-
era characterized by common pathogenic species, even
in this asymptomatic reference population. Finally, we
performed a complementary analysis of the metabolic
modules and enzymes detected in a subset of these body
sites, revealing strong variation in sugar and metal utili-
zation among the digestive tract communities.
Four distinct groups were delineated among the
microbial communities from the digestive tract sites.
The groups were rooted in the ratio of the relative
abundances of the two major phyla, Firmicutes and Bac-
teroidetes (Figure 1a), and the differences extended to
the genus level. In the absence of disease, these group-
ings suggest that it might be possible to sample one
representative site from each group in future studies as
a strategy to decrease sequencing costs. For example,
the buccal mucosa (Group 1), tongue dorsum (Group
2), supragingival plaque (Group 3) and stool (Group 4)
could be used to represent all ten sites examined here.
Samples from the suggested body habitats can be
obtained with minimal discomfort and risk to partici-
pants, and are likely to provide the biomass needed to
yield sufficient DNA for community whole genome
shotgun analysis. Since the current study includes only
healthy subjects, however, additional validation would
be required to investigate pre-disease and disease states
at targeted sites for both local and systemic diseases.
The oral microbiome as revealed in this investigation
was generally consistent with earlier studies
[11,13,14,22,66,67]. Firmicutes largely dominated the
microbial communities on oral tissue surfaces and in
saliva. Dental plaque taxa were more evenly distributed,
dominated by Firmicutes, Bacteriodetes, Actinobacteria,
Proteobacteria and Fusobacteria. The differences in the
plaque communities relative to oral tissue sites are likely
driven by the ability of the microbial community to
accumulate on the non-shedding tooth surface and the
physiological status relative to oxygen distribution in the
resulting biofilm. Porphyromonas, Tannerella and Trepo-
nema, genera consisting of recognized pathogens in per-
iodontal diseases, were highly prevalent. The presence of
these genera in greater than 95% of individuals in this
non-diseased population provides strong evidence that
they are part of the commensal oral microbiome. These
data suggest, rather than a complete absence of patho-
genic organisms from the normal microbiota, the possi-
bility of low-level carriage of potential pathogens
[68-70].
The stool microbiota was distinguished from the
microbiota of the upper digestive tract sites (Figure 1a),
as expected, and set apart by a high abundance of Bac-
teroidetes. A notable difference in the composition of
the stool microbiome of the HMP dataset compared to
existing 16S rRNA gene profiles is the increased ratio of
Bacteroidetes (>60% of the sequences) to Firmicutes
(≤30% of the sequences). Many previous studies of adult
American populations have observed the reverse, a pre-
ponderance of Firmicutes [15,71-73], and similar obser-
vations have been reported in geographically diverse
populations [74,75] and in infant gut microbiome colo-
nization investigations [76]. It should be noted that all
HMP gut communities were assayed from stool samples,
which may differ extensively from colonic biopsies. For
example, using endoscopic biopsies from just two sub-
jects, Wang et al. [77] reported 49% of 16S rRNA gene
clones were from the Firmicutes and 27.7% were from
Bacteroidetes. However, even this distinction is unclear,
as a study of 16S rRNA sequences from regional gut
biopsies and spontaneously passed stool involving three
subjects similarly showed the majority of phylotypes
belonged to Firmicutes (76%) compared to 16% for Bac-
teroidetes [15]. In a study of stool from 154 adult
women (twins and their mothers), Firmicutes had a
mean relative abundance of >60% using several different
methods to assess the 16S rRNA gene content of stool
[24]. Finally, a recently published study of fecal micro-
biota in 161 older subjects (≥65 years) corroborate our
findings, namely a Bacteroidetes-dominant distribution
(57%) compared to Firmicutes (40%) [26]. The difference
in the Firmicutes:Bacteroides ratio in stool samples ana-
lyzed by 16S rRNA composition was confirmed by
whole genome shotgun data from the same samples in
the HMP dataset [54]. While it is possible that these dif-
ferences are linked to any of geographic location, host
genetics, or differences in technical procedures, further
study will be critical in explaining these apparently dra-
matic variations in gut microbiota composition in adults.
An estimated 10
11 bacterial cells per day flow from
the mouth to the stomach [78,79]. Both cultivation and
molecular techniques demonstrate an overlap in the
oral, pharyngeal, esophageal and intestinal microbiomes
[12,27,28,75,80-85]. It has thus been hypothesized that
the oral microbiota might significantly contribute to dis-
tal digestive tract populations. Among HMP subjects,
the genera Bacteroides, Faecalibacterium, Parabacter-
oides, Eubacterium, Alistipes, Dialister, Streptococcus,
Prevotella, Roseburia, Coprococcus, Veillonella, and Osci-
libacter were detected in both the oral cavity and stool
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sequence reads did not permit species-level identifica-
tion, leaving open both the possibility that there are dis-
tinct distributions of species of these common genera
a l o n gt h ed i g e s t i v et r a c t ,a n dt h eq u e s t i o no fw h e t h e r
oral microbes seed distal sites below the stomach.
Based on the commonality of genera detected in the
upper digestive tract, we postulate that saliva, via its
impact on pH (as a buffer) and nutrient availability
(high mucin content) [86], is a key driver of microbial
composition in the habitats above the stomach. The
epithelium is likely another key driver as most of the
upper gastrointestinal mucosal surfaces share a common
epithelial lining (nonkeratinized, stratified, squamous
epithelium), with the exception of the keratinized gin-
giva, hard palate and parts of the tongue dorsum, which
instead share a keratinized, stratified, squamous epithe-
lium (Additional file 2). The upper digestive tract sites
are also constantly exposed to both inhaled and ingested
microbes. A substantial portion of the variability
observed in the upper digestive tract tract microbiota
might then be explained by interactions between the sal-
iva, host cell type, and exogenous factors such as oxygen
availability and oral intake.
In contrast to these potentially homogenizing effects,
the throat, among the nine upper digestive tract sites
sampled, is uniquely the recipient of small particles,
including microbes, that are trapped in mucus and pro-
pelled by respiratory cilia up from the trachea and down
from the nasal cavity en route to the stomach. This
might impose an additional selective pressure on phar-
yngeal microbiota. However, no such effect was evident
in the oropharynx, which segregated nicely into Group 2
with sites not exposed to the constant flow of respira-
tory tract mucus. Group 2, with the tongue, tonsils,
throat and saliva, is a reminder of the important overlap
between the upper segments of the digestive and
respiratory tracts: the aerodigestive tract, which consists
of the ‘lips, mouth, tongue, nose, throat, vocal cords,
and part of the esophagus and windpipe’ [87]. Evidence
suggests that the pool of microbes from Group 2, and
other oral sites, contribute to colonization of the airways
in disease. A few examples of this from the polymicro-
bial airway infections of cystic fibrosis follow: one of the
earliest cystic fibrosis pulmonary pathogens is Haemo-
philus influenzae, a common colonizer of the upper
aerodigestive tract [88]; members of the Streptococcus
milleri group were recently implicated as cystic fibrosis
pathogens [89], and are known colonizers of the oral
cavity; and lastly, members of the oropharyngeal micro-
biome might modulate the virulence of the key cystic
fibrosis pathogen Pseudomonas [90]. To explain micro-
bial community structure throughout the aerodigestive
tract and airways, one might speculatively extend the
basic argument above, noting that the counterpart of
saliva is mucus in regions not bathed by its flow, includ-
ing sites sampled by the HMP but not investigated here
(for example, the anterior nares) and habitats that
r e q u i r em o r ei n v a s i v em e t h o d sf o rs a m p l i n g( f o re x a m -
ple, nasal cavity, nasopharynx, esophagus and airways).
Several ‘environmental’ phyla observed in human
microbiota [33,91] appear to be strongly host-associated
in this study. The Synergistetes phylum, for example,
has only recently been described in detailed association
with the human oral cavity [36,92], and is still consid-
ered potentially environmental due to its common
occurrence in, for example, bioreactors [93,94].
Although completely absent from all ten sites in many
individuals, it conversely comprised up to 10% of the
community in some samples, and tended to recur at
multiple body habitats within the same individual. This
property - a dichotomy of apparent niches that includes
specific and potentially stable occupation of human
microbiome sites - can now be extended to TM7 and
SR1 based on the HMP oral cavity data. As sequencing
costs drop, deeper shotgun sequencing will provide
access to such organisms with higher confidence, as
most of those organisms are only known through their
phylogenetically conserved genes.
Conclusions
Analysis of the HMP dataset described here has pro-
vided a comprehensive characterization of the disease-
free digestive tract microbiome, and will further serve as
af o u n d a t i o nf o rt h es t u d yo fcomparable disease-asso-
ciated microbial communities. By surveying the HMP
population, these results can be further integrated into
other currently ongoing studies of the cohort’sc o r e
microbiome [9] or enterotype structure [25], if any. The
personalized nature of the digestive tract microbiota
revealed here speaks to its potential as a therapeutic tar-
get or point of intervention in genomic medicine, parti-
cularly as future studies are able to additionally account
for host genetic polymorphism. Few examples yet exist
where the overall composition, relative abundances, or
microbial proportions of a microbiome are conclusively
causal in human disease. However, it is clear that dis-
ease states are often associated with a disruption of the
microbial community, frequently resulting in one or a
few pathogenic organisms emerging [95,96]. A classic
example of this is the frequent ingestion of fermentable
sugars that leads to increases in the mutans strepto-
cocci, etiological agents of dental caries [97]. Similarly,
in the periodontal subgingival habitat, ecological shifts
in redox potential facilitate the emergence of anaerobic
pathogenic microbes such as the porphyromonads,
which are prevalent but in low abundance in the non-
diseased state [97,98]. It is likely that microbial
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be found to be prognostic indicators of future disease
status, and even this reference population could contain
as-yet-undetected pre-disease states. We thus hope that
this profile of the human microbiota will provide a
reference for subsequent investigations of its role in the
onset and alleviation of diseases along the human diges-
tive tract.
Materials and methods
Population recruitment, sample collection, and DNA
purification
Healthy adults 18 to 40 years old were recruited at two
academic centers [10]. Fifteen and 18 body habitats
were collected from enrolled males and females, respec-
tively. The sites sampled included anterior nares, oro-
pharynx (two specimens), oral cavity (seven specimens),
skin (four specimens), stool, and vagina (three speci-
mens per female) [10]. The Manual of Procedures and
the Core Microbiome Sampling Protocol are available at
the Data Analysis and Coordination Center for the
HMP [99], as well as dbGaP [100]. Genomic DNA was
isolated from the collected samples using the MO Bio
PowerSoil DNA Isolation Kit (MO BIO laboratories,
Inc., Carlsbad, California, USA) [10].
Sequencing and binning of 16S rRNA genes and read
processing
Detailed protocols used for 16S rRNA bacterial gene
amplification and sequencing, using the 454 FLX Tita-
nium platform and kits (Roche Diagnostic, Corp., India-
napolis, Indiana, USA), are available on the HMP Data
Analysis and Coordination Center website [99], and are
also described elsewhere [10]. In brief, sequences were
processed using a data curation pipeline implemented in
mothur [10,101] starting with quality trimmed for
homopolymer runs and a minimum 50 bp window aver-
age of 35. Any sequences not aligning against the appro-
priate subset of the SILVA database [102] were
removed, as were chimeric sequences. Resulting
sequences were processed using a data curation pipeline
implemented in mothur [10,101]. Remaining sequences
were classified with the MSU RDP classifier v2.2 [29]
using the taxonomy maintained at the RDP (RDP 10
database, version 6). Definition of a sequence’st a x o n -
omy was determined using a pseudobootstrap threshold
of 80% [10].
16S rRNA gene dataset post-processing and quality
control
A table of read counts from the 16S rRNA bacterial
gene pipeline was created by summing clade counts
from the three regions and was further processed for
removing low-coverage samples. Firstly, those taxa not
supported in the whole dataset by at least two sequences
in at least two samples were removed. Then, the quality
control procedure compared, for each sample, the read
count of the most abundant taxon t and the highest
abundance value that the same taxon t achieved in the
entire dataset. If the former term of the comparison is
<1% of the latter, the sample was discarded. Second,
third, and fourth time-point samples from the same sub-
jects were discarded. The resulting dataset of read
counts containing 2,105 samples is reported in Addi-
tional file 12, which represents 210 ± 7 samples per
body site. Further analysis of the dataset was performed
using the per sample normalization to relative abun-
dances. In the text, mean values are presented with
standard deviation. The number of subjects with sam-
ples in the digestive tract retained for the 16S rRNA-
based analysis was 209 post-quality control, from which
147 had sample data for all 10 body sites post-quality
control. Unless otherwise noted, only first visit samples
were used in all analyses.
Biomarker discovery and visualization
The characterization of functional and organismal fea-
tures differentiating the microbial communities specific
to different body sites in the digestive tract was per-
formed using our method for biomarker discovery and
explanation called LEfSe [30]. LEfSe, publicly available
[103], couples a standard test for statistical significance
with a quantitative test for biological consistency, finally
ranking the results by effect size. Briefly, it first uses the
non-parametric factorial Kruskal-Wallis test to detect
features (taxonomic clades or metabolic pathways) with
abundances that differ below a significance threshold
among groups of samples. Biological consistency is sub-
sequently tested using the unpaired Wilcoxon rank-sum
test among all pairs of sample groups; in our case this
occurred between single body habitats. Finally, linear
discriminant analysis (LDA) with bootstrapping is then
used to rank differentially abundant features based on
their effect sizes. A significance alpha of 0.05 and an
effect size threshold of 2 were used for all biomarkers
discussed in this study. Organismal and functional bio-
markers are graphically represented here on hierarchical
trees reflecting the RDP taxonomy [29] for 16S rRNA
gene data and the KEGG BRITE hierarchy [49] on
KEGG modules for metagenomic functional data.
Clustering and statistical significance of four groups of
body site habitats
For assessing bacterial community structure similarities
between different samples and body sites, we compared
the relative abundances of every pair of samples in our
dataset using the Bray-Curtis measure of beta diversity
[31]. The comparisons have been summarized in terms
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Table 1; moreover, statistical significance has been
tested for within versus between group distances, pro-
viding strong support (all P-values <10
-20)f o rt h ec l u s -
tering of all four groups in distinct community
structures. A multidimensional scaling analysis was then
performed on the Bray-Curtis diversity matrix and the
four groups were denoted with different colors for high-
lighting the clustering structure (Additional file 4).
Whole genome shotgun sequencing, read processing, and
community metabolic profiling
Whole genome shotgun sequencing employed the Illu-
mina GAIIx platform (Illumina, Inc.) as previously
described [10]. The number of samples and nucleotide
content from 98 subjects is summarized in Additional
file 12. The abundances and presence (or absence) of
pathways in these metagenomic data were inferred using
the HUMAnN pipeline (HMP Unified Metabolic Analy-
sis Network) [48]. Briefly, the metabolic and biomolecu-
lar potential of each sample was profiled starting from
the 100 bp Illumina sequences after quality and length
filtering. Reads were mapped to KEGG v54 orthologous
gene families (KEGG KOs [49]) using MBLASTX (Mul-
ticoreWare, St. Louis, MO, USA), an accelerated trans-
lated BLAST implementation, using default parameters
and a maximum E-value of 1. Hits were mapped to
abundances of each KO using up to the 20 most signifi-
cant hits, weighted by the quality of each hit (inverse
blastx P-value) and normalized by the length of the hit
gene. Pathway information was then recovered by
assigning KO gene families to KEGG modules (repre-
senting small pathways of approximately 5 to 20 genes)
using a combination of MinPath [104], filtering of path-
ways not consistent with the BLAST-derived taxonomic
composition of the community, and gap filling of likely
missing enzymes. The resulting KO and KEGG module
relative abundances were used in the presented analysis.
Further details of the HUMAnN methodology, its soft-
ware implementation, and an extensive validation of
each computational step appear in [48].
Data accessibility
The datasets used in these analyses were deposited by
the NIH Common Fund Human Microbiome Consor-
tium at the Data Analysis and Coordination Center
(DACC) for the Human Microbiome Project. Specifi-
cally, the downloadable packaged datasets are the 16S
rRNA gene dataset [105], phylotype-classification of the
16S rRNA gene dataset [106,107], Human Microbiome
Illumina whole genome shotgun reads [108], and the
metabolic reconstruction tables [109]. The phylotype
classification processed for normalization and quality
control is available in Additional file 7.
Additional material
Additional file 1: Table s1 - average abundance, expressed in
percentage of all microbial clades in the four digestive tract groups
and among the ten body habitats. Lettering of groups and body
habitats are as in Figure 1. AVG, average; STDEV, standard deviation.
Additional file 2: Table s2 - surfaces associated with the sampling
sites from which the microbiota of the digestive tract was collected.
Additional file 3: Figure s1 - higher resolution version of Figure 1b
showing significantly enriched taxa from the four groups of
digestive tract sites. This circular cladogram reports significant group-
enriched taxa. Differential taxa analysis was performed using LEfSe on all
the samples. Colored shading highlights which of the four major
bacterial phyla was most enriched in which of the four body site groups.
Each colored dot indicates a taxon that was differentially abundant
among the groups. Small letters denote bacterial families that were
enriched in one of the four body site groups.
Additional file 4: Figure s2 - diversity-based multidimensional
scaling (MDS) plot of samples. A distance matrix for all pairwise
distances between samples was calculated using Bray-Curtis distance,
which was used to project samples to MDS coordinates using the stats::
cmdscale R function with default options. Each of the four established
groups of body sites (G1, G2, G3, G4) is assigned a color, decreasing in
opacity as the density of points of that group decreases, and body sites
are denoted with different marker types. G2 and G3 contain the most
overlap, while maintaining distinct areas of highest density, while G1 and
G4, respectively, increase in distinctness. The distribution of samples in
specific body sites does not produce sub-clusters, confirming the
homogeneity of bacterial community composition within the four
groups.
Additional file 5: Table s3 - inverse Simpson for each habitat of the
digestive tract. The minimum, maximum, average and standard
deviation values are reported.
Additional file 6: Table s4 - percentages of subjects for whom each
taxon was detected in both the upper digestive tract and in the
stool. The table is ordered based on the absolute differences between
the presence in the stool and in at least one oral body site. Only the
subjects with samples in all ten digestive tract body habitats were
considered (n = 147) and all the taxonomic units with at least 40% of
presence in stool or any oral body site are included.
Additional file 7: Table s5 - read counts for all digestive tract
samples (after quality control) for each microbial clade.
Additional file 8: Figure s3 - visual and schematic representation of
the oral cavity and oropharyngeal sampling sites. The soft tissues,
illustrated here in a 20-year-old healthy male, were sampled by swabbing
the tongue dorsum, hard palate, right and left buccal mucosa, the
anterior keratinized gingiva, the right and left palatine tonsils, and the
throat (posterior wall of the oropharynx). The pooled supragingival and
pooled subgingival plaque samples were taken with curettes from
molars, premolars and incisors (schematic illlustration). Not shown is the
sampling of the saliva, which was collected by having the subject drool
accumulated saliva into a collection vial. The complete sampling
procedure is described in the Manual of Procedures for Human
Microbiome Project (see Materials and methods).
Additional file 9: Figure s4 - higher resolution version of Figure 6
showing functional characterization of the digestive microbiota.
Differentially abundant metabolic pathways from the buccal mucosa,
supragingival plaque, tongue dorsum, and stool are depicted based on
metabolic profiling performed with HUMAnN [48] from metagenomic
shotgun sequencing data. Lettering indicates metabolic modules.
Nucleot./amino acid met., nucleotide and amino acid metabolism;
Carbohydrate/lipid met., carbohydrate and lipid metabolism; Energy met.,
energy metabolism; Met., aminoacyl tRNA and nucleotide sugar
metabolism; Genetic information proc., genetic information processes;
Environmental inf. proc., environmental information processing.
Additional file 10: Table s6 - percentages of metagenomic reads
assigned to Archaea, Bacteria, and non-human Eukaryota (human
Segata et al. Genome Biology 2012, 13:R42
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Page 15 of 18reads excluded) in the four digestive tract sites with more than 50
shotgun sequencing samples available.
Additional file 11: Figure s5 - a subset of significant correlations
between metagenomic gene family and organismal abundances.
Paired shotgun metagenomic and 16S rRNA gene sequencing samples
were associated, resulting in 34 buccal mucosa, 35 stool, 33 supragingival
plaque, and 30 tongue microbiomes for joint analysis. Within each body
site, Spearman correlations were calculated between the 21 KEGG
Orthology gene families described in the Results and all phylotypes at
any taxonomic level from phylum to OTU. Significant associations
reaching a Benjamini-Hochberg false discovery rate <0.05 are shown
here; grey ellipses represent clades, white rectangles KO gene families,
and edge width is proportional to -log(q-value). Colors are as in Figure 1
(red, buccal mucosa; green, stool; yellow, plaque; blue, tongue).
Additional file 12: Table s7 - summary of the read statistics for 16S
rRNA gene taxonomic abundances and whole genome shotgun
sequencing metagenomic data.
Abbreviations
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Network; KEGG: Kyoto Encyclopedia of Genes and Genomes; KO: KEGG
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